$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
7 Cathie Wood Stocks Every Growth Investor Needs In Their Portfolio
03:28pm, Tuesday, 28'th Sep 2021
These top seven stocks among Cathie Wood's top holdings are ones investors may be enticed to consider right now. The post 7 Cathie Wood Stocks Every Growth Investor Needs In Their Portfolio appeared f
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
07:07pm, Wednesday, 22'nd Sep 2021
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $117.81, moving +0.48% from the previous trading session.
Is Now the Time to Ditch Pharma Stocks?
06:45am, Tuesday, 21'st Sep 2021
With drug pricing reform on the horizon, investors may want to analyze their allocation.
Why CRISPR Therapeutics AG (CRSP) is a Top Stock for the Long-Term
10:42am, Friday, 17'th Sep 2021
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
3 Explosive Biotech Stocks That Could 10X in 10 Years
05:55am, Thursday, 16'th Sep 2021
They're leaders in therapeutic areas with massive growth potential.
7 Gene Editing Stocks Promising to Change our DNA
12:45pm, Wednesday, 15'th Sep 2021
Gene editing stocks will take off as the underlying tech moves from fiction to fact and companies put their products on the market. The post 7 Gene Editing Stocks Promising to Change our DNA appeared
7 Cathie Wood Stock Favorites to Keep on Your Radar
10:19am, Friday, 10'th Sep 2021
Cathie Wood and her funds are generating a lot of interest among investors for smart picks, and these Cathie Wood stocks are worth a look. The post 7 Cathie Wood Stock Favorites to Keep on Your Radar
3 Cathie Wood Stocks To Trade for Bulls as Well as Bears
10:05am, Thursday, 09'th Sep 2021
As the saying goes, bulls and bears make money. And today in these three Cathie Wood stocks both camps should be ready for action The post 3 Cathie Wood Stocks To Trade for Bulls as Well as Bears appe
Could CRISPR Therapeutics Stock Help You Retire a Millionaire?
09:40am, Tuesday, 31'st Aug 2021
A crowded field could take years to thin out.
Crispr Therapeutics: Lucrative Partnerships And Promising Data Increase Its Appeal
03:48am, Saturday, 28'th Aug 2021
CRISPR Therapeutics' clinical programs are progressing nicely, showing excellent safety and efficacy, validating the prospects of its novel technology as a disruptive force in the biotech industry. Di
Earnings Growth & Price Strength Make CRISPR Therapeutics AG (CRSP) a Stock to Watch
10:41am, Tuesday, 24'th Aug 2021
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
What's Next For CRISPR Stock After An 11% Fall In A Week?
08:30am, Friday, 20'th Aug 2021
The stock price of CRISPR Therapeutics, a biotechnology gene editing company focused on developing gene-based medicines for human diseases, reached an all-time high of $210 in January of this year bef
Updated Clinical and Financial Data Make the Case for CRISPR Therapeutics
08:07am, Thursday, 19'th Aug 2021
Looking for a terrific value in the biotechnology space? It doesn't get much better than CRSP stock, which just entered a buy zone.
How Are Genomics ETFs Responding to Q2 Earnings?
10:00am, Saturday, 14'th Aug 2021
Let's take a look at some big genomics earnings releases to see if these will impact ETFs exposed to the space.
Why CRISPR Therapeutics Stock Fell 25.2% in July
02:29pm, Friday, 06'th Aug 2021
The stock dropped roughly $40 per share over the course of the month.
Sign In
Buy CRSP